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Background: The overstimulation of excitatory glutamatergic neurotransmission and the inhibition of Na+,K+-ATPase
enzymatic activity have both been implicated in neurotoxicity and are possibly related to the pathogenesis of epilepsy
and neurodegenerative disorders. In the present study, we investigated whether glutamatergic stimulation by the
glutamatergic agonists glutamate, α-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA), kainate and N-
methyl-D-aspartate (NMDA) modulates the Na+,K+-ATPase and the K+-p-nitrophenylphosphatase activities in the crude
synaptosomal fraction of the hippocampus and the frontal cortex of rats.
Results: Our results demonstrated that these glutamatergic agonists did not influence the activities of Na+,K+-ATPase
or K+-p-nitrophenylphosphatase in the brain structures analyzed. Assays with lower concentrations of ATP to analyze
the preferential activity of the Na+,K+-ATPase isoform with high affinity for ATP did not show any influence either.
Conclusions: These findings suggest that under our experimental conditions, the stimulation of glutamatergic
receptors does not influence the kinetics of the Na+,K+-ATPase enzyme in the hippocampus and frontal cortex.
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Glutamate is the main excitatory neurotransmitter in the
central nervous system [1], and the overstimulation of glu-
tamatergic receptors, including the ionotropic receptors of
N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-
5-methyl-isoxazole-4-propionic acid (AMPA), seems to be
related to neuronal death caused by excitotoxicity [1,2].
Glutamate-induced neurotoxicity apparently underlies a
variety of neurologic disorders, including epilepsy, Hun-
tington’s disease, Parkinson’s disease and Alzheimer’s dis-
ease [1]. Excessive accumulation of glutamate in the
synaptic cleft can be due to higher glutamate release, lower
uptake by pre-synaptic terminals and/or reverse transpor-
tation of glutamate from the pre-synaptic terminal towards* Correspondence: mmmarcos@uol.com.br
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distribution, and reproduction in any mediumthe synaptic cleft [2,3]. These processes can result from
alterations in the Na+ and K+ concentration gradients be-
tween the intracellular and extracellular environments,
which depend on the activity of the transmembrane en-
zyme Na+,K+-ATPase [4-6].
Na+,K+-ATPase is the enzyme responsible for the main-
tenance of low concentrations of Na+ and high concentra-
tions of K+ in the intracellular environment, maintaining
the resting potential and aiding in the reestablishment of
this potential after neuronal depolarization [5]. Structurally,
Na+,K+-ATPase is a heterotrimer formed by three subunits
(α1-4, β1-3 and γ), and the kinetic properties of the isozymes
are mainly determined by the α subunit [7]. In the central
nervous system, α1 and α2 function as the “housekeeping”
isoforms, while the α3 isoform is predominantly activated
in situations involving high neuronal activity [8,9]. The in-
hibition of Na+, K+-ATPase activity by the glycoside oua-
bain elicits an excitatory effect leading to convulsionsCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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crosis [6]. Additionally, a deficiency in Na+,K+-ATPase ac-
tivity has been linked to central nervous system disorders,
including epilepsy and neurodegenerative diseases [4,6].
Several in vitro studies have been performed in an at-
tempt to understand whether and how glutamatergic acti-
vation influences the kinetics of Na+,K+-ATPase in nervous
tissue. The results, however, have not been consistent. Al-
though some researchers have reported a stimulation of
Na+,K+-ATPase enzymatic activity by glutamatergic ago-
nists [12-14], others have demonstrated an inhibition of its
activity [15-19] or neither stimulation nor inhibition
[20,21]. It is worthwhile to mention that such contradic-
tions may be due to some technical factors, including dif-
ferences in brain tissues, tissue preparation and the
biochemical assays performed; for example, 42K+ uptake
has been analyzed using scintillation counting [12], Rb+
uptake has been analyzed using atomic absorption spec-
troscopy [19] or scintillation counting [14] and inorganic
phosphate release has been analyzed using spectrophotom-
etry [15-17,20,21] and scintillation counting [13]. The
results can also be discrepant depending on the family of
glutamatergic receptor that is being stimulated [16,18,19].
Therefore, the present study sought to verify whether
different concentrations of glutamate and the ionotropic
glutamatergic agonists NMDA, AMPA and kainate would
alter the kinetic behavior of Na+,K+-ATPase in the crude
synaptosomal fraction of the hippocampus and the frontal
cortex. These studies were performed using two different
biochemical methods. The first method was a Na+,K
+-ATPase assay involving the complete enzymatic reac-
tion, including both Na+-dependent phosphorylation and
K+-dependent dephosphorylation. The second method
was a K+-p-nitrophenylphosphatase (K+-p-NPPase) assay
involving only K+-dependent dephosphorylation. In the
Na+,K+-ATPase assay, we performed studies with both sat-
urating and sub-saturating concentrations of ATP. Under








Control 149.7 ± 15.6 56.48 ± 4.2 280.4 ± 33.8
Glutamate 146.6 ± 25.7 54.83 ± 4.2 299.7 ± 40.9
Control 143 ± 8.5 48.24 ± 3.1 302.8 ± 33.3
NMDA 148.1 ± 10.3 45.39 ± 3.3 274.7 ± 38.7
Control 131.5 ± 6.5 49.74 ± 2.4 313.9 ± 51.6
AMPA 139.1 ± 6.7 48.64 ± 4.7 325.9 ± 36.7
Control 134.3 ± 10.5 47.64 ± 5.1 310.7 ± 69.7
Kainate 142.9 ± 15.2 45.4 ± 5.1 319.7 ± 51.9
Values are expressed as mean± standard deviation (5 animals/group). ATPases activ
expressed in nmol of p-nitrophenol/mg protein/min. The concentrations of the subcontaining α1, α2 and α3 are indistinguishable. At lower
ATP concentrations, isozymes containing α3 can be pre-
ferentially assayed because they have a higher affinity for
ATP [9]. Concomitant with these assays, we also investi-
gated a putative influence of the glutamatergic agonists on
the activities of ouabain-insensitive Mg2+-ATPase and
Mg2+-p-nitrophenylphosphatase (Mg2+-p-NPPase).Results
Tables 1, 2, 3, 4, 5, and 6 show the values (mean± standard
deviation; N=4-5/group) of K+-p-NPPase, Mg2+-p-NPPase,
Na+,K+-ATPase and Mg2+-ATPase activities in the frontal
cortex and hippocampus, respectively. The analysis of data
using the unpaired Student’s t-test demonstrated no
statistical differences in the activities of K+-p-NPPase,
Mg2+-p-NPPase, Na+,K+-ATPase and Mg2+-ATPase in
the presence (experimental group) or absence (control
group) of the glutamatergic agonists utilized. The control
and the experimental groups correspond to the same tis-
sue suspensions, and their enzymatic activities were all
assayed simultaneously. Five different animals were used
for each agonist concentration value (NTOTAL: 15 animals).Discussion
The literature has elucidated how alterations in Na+,
K+-ATPase activity influence glutamatergic neuro-
transmission and how both of these elements are
correlated to neurotoxicity, possibly contributing to a
variety of neurological disorders, including epilepsy
and neurodegenerative diseases. The excitatory effect
and the apoptotic/necrotic processes elicited by the
inhibition of Na+,K+-ATPase activity in the central
nervous system are probably due to several factors:
(a) a decrease in the threshold to trigger subsequent
action potentials because the accumulation of Na+
leads to a lower intracellular electronegativity [6], (b)







158.6 ± 22.8 129.5 ± 15.9 109.9 ± 7.4
148.8 ± 26.2 125.6 ± 12.1 107.9 ± 11.2
139.3 ± 10.7 128.6 ± 25 61.93 ± 5.8
148.2 ± 11.8 134.4 ± 26.2 63.45 ± 5.8
178.2 ± 28.8 138.6 ± 24.6 70.42 ± 3.8
180 ± 14.3 146.8 ± 20.6 63.26 ± 8.7
147.7 ± 15.2 149.3 ± 13.2 81.58 ± 6.9
130.3 ± 13.4 144.6 ± 18.1 83.61 ± 9.8
ities are expressed in nmol of Pi/mg protein/min, and p-PNPPases activities are
strates are shown in parentheses.














Control 164.3 ± 5.8 28.3 ± 6.5 339.1 ± 89.4 209.5 ± 34.6 198 ± 33.9 99.2 ± 7.4
Glutamate 166.9 ± 8.7 27.2 ± 5.4 355.3 ± 70.6 197.9 ± 36.4 202.8 ± 24.8 91.5 ± 8.9
Control 136.7 ± 13.4 40.8 ± 4.7 463.9 ± 67.1 159.3 ± 22.8 201.2 ± 32.6 94.5 ± 6.7
NMDA 140 ± 12.5 37.4 ± 7.1 432.5 ± 27.7 156.9 ± 38.5 190.4 ± 26.6 94.4 ± 6.5
Control 110.9 ± 12.7 41.5 ± 7.6 407.9 ± 61.9 238.8 ± 41.8 200.6 ± 26.6 79.7 ± 10.3
AMPA 114.4 ± 10.5 38.4 ± 5.6 412.1 ± 74 221.5 ± 42.9 188.3 ± 27.5 71.6 ± 6.3
Control 133 ± 5.2 43.7 ± 7.8 316 ± 119.4 144.9 ± 15.2 205.4 ± 21 83.6 ± 12
Kainate 131.9 ± 11.8 40.3 ± 8 374.7 ± 82.3 124.8 ± 19.7 205.5 ± 22.4 74.5 ± 7.8
Values are expressed as mean± standard deviation (4–5 animals/group). ATPases activities are expressed in nmol of Pi/mg protein/min, and p-PNPPases activities
are expressed in nmol of p-nitrophenol/mg protein/min. The concentrations of the substrates are shown in parentheses.
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pre-synaptic uptake of glutamate from the synaptic
cleft, a Na+-dependent process [2] and (d) the non-
vesicular liberation of glutamate from the intracellular
to the extracellular environment through the process
of inverse transport by the glutamate transporters
[2,3].
Nevertheless, it is still unclear whether and how Na+,
K+-ATPase is influenced by the stimulation of glutama-
tergic receptors. It has been previously demonstrated
that glutamatergic ionotropic agonists stimulate, in a
dose-dependent manner, the total activity of Na+,K+-
ATPase in primary cultures of rat cerebral neurons [12].
This result is in agreement with other studies using cultures
of cerebellar neurons from rats [13] and in cultures of cere-
bral cortical astrocytes of mice [14], although these studies
only used the neurotransmitter glutamate. However, a de-
crease in Na+,K+-ATPase activity after glutamatergic
stimulation by NMDA receptor agonists has been
observed in slices of rat cerebral cortex [19] and in cere-
bellar granule cells [16-18]. In another study, a decrease in








Control 162.2 ± 10 66.4 ± 3.3 303.8 ± 32.4
Glutamate 177.5 ± 15 65.2 ± 5.8 343.6 ± 72.2
Control 214.0 ± 23.2 65.1 ± 3.1 283.5 ± 30.4
NMDA 215.5 ± 16.1 69.5 ± 6.7 270.6 ± 78.9
Control 168.1 ± 13.6 61.6 ± 2.4 407.0 ± 53.4
AMPA 170.1 ± 13.6 61.6 ± 5.4 383.7 ± 79.8
Control 162.9 ± 6.9 66.2 ± 3.6 341.0 ± 39.8
Kainate 171.3 ± 9.4 65.8 ± 7.6 346.1 ± 80.3
Values are expressed as mean± standard deviation (5 animals/group). ATPases activ
expressed in nmol of p-nitrophenol/mg protein/min. The concentrations of the subcortex synaptosomes using glutamate [15]. Other studies
found neither stimulation nor inhibition of Na+,K
+-ATPase activity in the presence of different concentra-
tions of glutamate in mouse brain synaptosomes [20] or in
synaptosomes from the cerebral cortex from rats [21].
The enhancement of Na+,K+-ATPase activity could be
interpreted as a negative feedback mechanism with a pro-
tective effect against glutamate neurotoxicity. On the
other hand, the decrease in the Na+,K+-ATPase activity
could be interpreted as a positive feedback mechanism
that would potentiate glutamate neurotoxicity.
The current work indicated that the stimulation of glu-
tamatergic receptors did not influence the Na+,K+-ATPase
activity in the frontal cortex and hippocampus, as analyzed
using the K+-p-NPPase and Na+,K+-ATPase methods.
Assays performed under high concentrations of Na+,K+
and ATP simulated a situation of high neuronal activity
[8,9], such as those elicited by glutamatergic hyperactivity,
when the isozymes are indistinguishably activated. On the
other hand, assays performed under lower concentrations
of ATP simulated a situation of intense and prolonged







124.4 ± 13.2 154.0 ± 15.9 129.9 ± 16.1
104.8 ± 17.2 149.2 ± 10.5 126.8 ± 10.7
192.8 ± 23.2 134.6 ± 15.9 139.3 ± 7.8
174.3 ± 31.7 130.7 ± 17.2 131.9 ± 12.5
219.7 ± 21.5 159.5 ± 10.9 128.1 ± 13.6
195.4 ± 36 146.3 ± 25 122.7 ± 10.1
192.0 ± 22.4 161.0 ± 17.9 129.0 ± 14.5
166.8 ± 16.3 148.8 ± 28.8 127.1 ± 10.5
ities are expressed in nmol of Pi/mg protein/min, and p-PNPPases activities are
strates are shown in parentheses.














Control 155.8 ± 7.4 52.6 ± 1.8 370.7 ± 26.2 205.4 ± 6.5 152.9 ± 13.9 149.7 ± 16.8
Glutamate 153.3 ± 6 56.2 ± 4.9 364.9 ± 32.9 189.4 ± 14.5 166.6 ± 21.5 136.3 ± 11.4
Control 175.0 ± 10.5 56.1 ± 2.4 348.7 ± 45.2 211.6 ± 16.8 156.1 ± 26.4 156.6 ± 13.6
NMDA 176.7 ± 13 57.0 ± 3.3 379.0 ± 21.7 195.8 ± 18.8 143.1 ± 18.5 155.6 ± 18.5
Control 129.7 ± 10.3 57.9 ± 5.8 360.8 ± 24.1 239.6 ± 13.2 146.1 ± 16.5 171.8 ± 23.5
AMPA 142.6 ± 16.3 55.8 ± 3.1 364.9 ± 19.7 230.0 ± 12.5 146.2 ± 12.1 165.5 ± 12.1
Control 189.0 ± 10.5 58.0 ± 3.3 345.6 ± 32 237.0 ± 16.3 180.1 ± 12.5 170.0 ± 22.6
Kainate 184.0 ± 9.8 60.8 ± 2.9 336.9 ± 44.7 221.2 ± 12.9 163.8 ± 22.6 164.3 ± 20.6
Values are expressed as mean± standard deviation (5 animals/group). ATPases activities are expressed in nmol of Pi/mg protein/min, and p-PNPPases activities are
expressed in nmol of p-nitrophenol/mg protein/min. The concentrations of the substrates are shown in parentheses.
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leptiform activity [24] and glutamate-induced neurotox-
icity [25], and revealed a preferential activity of isozymes
containing α3. However, we did not find any statistical dif-
ferences. The lack of differences in our study is in agree-
ment with previous reports in which glutamate did not
alter the enzymatic activity in brain synaptosomes of mice
[16] and the cerebral cortex of rats [17], although in this
last case, the enzymatic reaction was conducted in the
presence of a soluble brain fraction containing Na+,
K+-ATPase modulators. In another study that utilized rat
cerebral cortex slices, neither kainate nor AMPA changed
Na+,K+-ATPase activity, although NMDA receptor ago-
nists decreased it [14]. The agonists concentrations used
in our study (50 μM, 300 μM and 1 mM) are compatible
with the previous researches, in which were used glutama-
tergic agonists between micromolar and milimolar range
[12-21]. Thus, it is highly unlikely that the lack of differ-
ence in our study is due to the agonists concentrations. It
is possible that the age of the animals represents an im-








Control 169.6 ± 19.4 53.7 ± 3.3 289.4 ± 22.4
Glutamate 167.2 ± 20.3 55.0 ± 3.1 255.2 ± 35.3
Control 169.4 ± 8.9 53.4 ± 3.6 305.7 ± 22.1
NMDA 168.5 ± 3.1 53.8 ± 2.4 275.3 ± 38.9
Control 172.5 ± 11.2 41.7 ± 2.9 265.2 ± 36.4
AMPA 174.2 ± 17.4 41.2 ± 1.8 304.0 ± 21
Control 165.3 ± 18.5 57.6 ± 1.8 296.8 ± 46.9
Kainate 179.9 ± 23.7 55.5 ± 6.9 257.8 ± 35.1
Values are expressed as mean± standard deviation (5 animals/group). ATPases activ
expressed in nmol of p-nitrophenol/mg protein/min. The concentrations of the subenzymatic reaction with brain tissues from adult rats, the
studies using the primary cultured cells were derived from
rats with only a few days old.
Conclusions
Therefore, the data obtained in the present work suggest
that under the present experimental conditions, the
stimulation of glutamatergic receptors does not influ-
ence the Na+,K+-ATPase activity in the frontal cortex
and hippocampus. Further in vitro studies need to be
performed, under different conditions, using different
brain structures, tissue preparations, technical analysis
and ages of the animals, in order to reach a better
understanding of the relationship between glutamatergic
activation and Na+,K+-ATPase activity.
Material and methods
Animals
Subjects were naïve adult male Wistar rats aged three
months and weighing approximately 350 g. They were







138.7 ± 14.7 173.0 ± 31.7 192.8 ± 22.3
129.5 ± 5.8 162.4 ± 6.5 170.5 ± 24.8
159.5 ± 18.5 161.6 ± 10.9 188.4 ± 16.1
146.7 ± 7.1 157.5 ± 17.7 176.8 ± 12.3
202.4 ± 12.7 141.4 ± 15.9 165.5 ± 24.3
213.4 ± 17.7 136.7 ± 19.4 167.6 ± 12.1
205.8 ± 17.7 154.6 ± 13.4 166.7 ± 12.5
189.6 ± 13.4 149.3 ± 27.7 163.7 ± 11.6
ities are expressed in nmol of Pi/mg protein/min, and p-PNPPases activities are
strates are shown in parentheses.














Control 140.8 ± 19.4 52.6 ± 4.5 286.6 ± 25.3 205.7 ± 25.9 146.7 ± 14.5 141.7 ± 14.5
Glutamate 143.2 ± 9.8 52.5 ± 3.3 271.2 ± 36 190.0 ± 14.5 136.2 ± 14.7 145.4 ± 18.1
Control 107.2 ± 7.6 54.9 ± 5.8 327.2 ± 22.1 211.8 ± 22.1 137.9 ± 12.1 149.4 ± 10.9
NMDA 109.3 ± 9.2 56.7 ± 3.3 320.3 ± 32.4 204.6 ± 16.1 125.5 ± 10 150.1 ± 4.9
Control 163.1 ± 15.2 49.7 ± 6 300.6 ± 18.5 192.0 ± 28.6 156.2 ± 12.7 153.3 ± 17.7
AMPA 159.5 ± 21.2 50.9 ± 3.3 304.7 ± 15.6 187.3 ± 8.9 155.3 ± 21 150.3 ± 15.4
Control 134.0 ± 11.6 52.5 ± 4.7 290.7 ± 15.6 191.9 ± 20.1 154.2 ± 18.8 149.6 ± 18.1
Kainate 134.8 ± 10.1 54.1 ± 1.6 276 ± 31.7 172.3 ± 13.2 137.3 ± 13 148.6 ± 13.6
Values are expressed as mean± standard deviation (5 animals/group). ATPases activities are expressed in nmol of Pi/mg protein/min, and p-PNPPases activities are
expressed in nmol of p-nitrophenol/mg protein/min. The concentrations of the substrates are shown in parentheses.
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(23 ± 2°C) with a 12:12 h light–dark cycle (lights on
from 7:00 a.m. to 7:00 p.m.) with ad lib food and water.
This work was approved by our institution’s Ethics
Committee on Animal Research (Proc. 0851/10).
Assays of the enzymatic activities of K+-p-NPPase and
Mg2+-p-NPPase
The activity of Na+,K+-ATPase occurs through two fun-
damental steps, the Na+-dependent phosphorylation and
the K+-dependent dephosphorylation. While the activity
of Na+,K+-ATPase includes both of these steps, which
result in the hydrolysis of the natural substrate ATP into
ADP and inorganic phosphate (Pi), the activity of
K+-p-NPPase consists of the hydrolysis of the arti-
ficial substrate p-nitrophenylphosphate into p-nitrophenol
and Pi and corresponds to K
+-dependent dephosphoryla-
tion by Na+,K+-ATPase.
The animals were sacrificed by decapitation. The
brains were carefully removed and washed with ice-cold
0.9% (w/v) saline solution, and the frontal cortex and
hippocampus were rapidly dissected on a cooled petri
dish on crushed ice. After weighing, these structures
were stored at −20°C until the preparation of homoge-
nates. The K+-p-nitrophenylphosphatase assay was per-
formed as previously described [26]. The homogenates
of the brain structures were prepared in ice-cold 0.32 M
sucrose (pH 7.0) (2.5%w/v) using a glass homogenizer
tube and a motor-driven Teflon pestle. The homoge-
nates were centrifuged at 900 x g for 10 min at 4°C, and
the resulting supernatants were centrifuged at 23,000 x g
for 20 min at 4°C. The supernatants were discarded, and
the pellets were resuspended in 50 mM Tris/HCl (pH 7.4)
containing 1 mM EDTA and centrifuged at 23,000 x g for
20 min at 4°C. The supernatants were discarded, and the
pellets were resuspended in 50 mM Tris/HCl (pH 7.4)
containing 1 mM EDTA. In small glass test tubes, the total
p-nitrophenylphosphatase activity was assayed in anincubation medium consisting of 40–60 μg protein of the
homogenate, 50 mM Tris/HCl (pH 7.4), 5 mM MgCl2,
10 mM p-nitrophenylphosphate and 10 mM KCl in the
presence or absence of glutamate (SigmaW), kainate
(SigmaW), AMPA (SigmaW) or NMDA (SigmaW)
(50 μM, 300 μM or 1 mM), resulting in a final volume
of 100 μL. The ouabain-insensitive Mg2+-p-NPPase ac-
tivity was determined in a similar medium that was de-
ficient in K+. The reactions were incubated in a shaking
water bath for 10 min at 37°C. The reaction was stopped
by adding 100 μL trichloroacetic acid (10%w/v), the test
tubes were centrifuged, and a 100-μL aliquot of the
cleared supernatant was transferred into a test tube con-
taining 600 μL of 1 M Tris-base solution. The samples
were read in a spectrophotometer at a wavelength of
410 nm. K+-p-NPPase activity was calculated by subtract-
ing the reaction in the absence of KCl from the reaction in
presence of KCl. A standard curve was calculated using
six distinct amounts of p-nitrophenol ranging from 10–
120 nmol. The protein in the homogenates was quantified
using bovine serum albumin as a standard [27]. The final
results are expressed as nmol of p-nitrophenol released/
mg protein/min.
Assays of the enzymatic activities of Na+,K+-ATPase and
Mg2+-ATPase
The Na+,K+-ATPase assays were performed as previ-
ously described [28], with some modifications. The
homogenates of the brain structures were the same as
those used for the K+-p-nitrophenylphosphatase
assays. In small glass test tubes, the total ATPase ac-
tivity was assayed in an incubation medium consisting
of 8–12 μg protein of the homogenate, 150 mM Tris/
HCl (pH 7.4), 4 mM MgCl2, 9 mM (or 2 mM) ATP,
70 mM NaCl and 40 mM KCl in the presence or absence
of glutamate, kainate, AMPA or NMDA (50 μM, 300 μM
or 1 mM), resulting in a final volume of 90 μL. The
ouabain-insensitive Mg2+-ATPase activity was determined
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contained 1 mM ouabain. The reactions were incubated
in a shaking water bath for 30 min at 37°C. The reaction
was stopped by adding 20 μL trichloroacetic acid (30%w/v),
the test tubes were centrifuged, and a 50 μL aliquot of the
cleared supernatant was used for determination of
released orthophosphate [29]. The samples were read in a
spectrophotometer at a wavelength of 820 nm. Na+,
K+-ATPase activity was calculated by subtracting the re-
action in the absence of NaCl and KCl and containing
ouabain from the reaction in the presence of NaCl and
KCl and lacking ouabain. A standard curve was calculated
using three distinct amounts of Na2HPO4 ranging from
25–100 nmol (Additional files 1, 2, 3, 4, and 5). The pro-
tein in the homogenates was quantified using bovine
serum albumin as a standard [27]. The final results are
expressed as nmol of Pi released/mg protein/min.Statistical analysis
The unpaired Student’s t-test was used to compare the ac-
tivities of Na+,K+-ATPase, K+-p-NPPase, Mg2+-p-NPPase
and Mg2+-ATPase in the presence and absence of the glu-
tamatergic agonists. The significance level was set at
p≤ 0.05 for all statistical tests. The statistical analyses were
performed using Statistica version 6.1. and Prism 3.0.Additional files
Additional file 1: Standard curve depicting the linear relationship
between absorbance and amounts of Pi (25, 50 and 100 nmoles).
This interval comprises the amount of Pi released in our enzymatic assay.
Additional file 2: Standard curve depicting the linear relationship
between absorbance and amounts of Pi (25, 50 and 100 nmoles).
This interval comprises the amount of Pi released in our enzymatic assay.
Additional file 3: Standard curve depicting the linear relationship
between absorbance and amounts of Pi (25, 50 and 100 nmoles).
This interval comprises the amount of Pi released in our enzymatic assay.
Additional file 4: Standard curve depicting the linear relationship
between absorbance and amounts of Pi (25, 50 and 100 nmoles).
This interval comprises the amount of Pi released in our enzymatic assay.
Additional file 5: Standard curve depicting the linear relationship
between absorbance and amounts of Pi (25, 50 and 100 nmoles).
This interval comprises the amount of Pi released in our enzymatic assay.
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